undamentalytics Newsletter
Sign in

SBC Medical Group Holdings Inc income statement

In fiscal 2025, SBC Medical Group Holdings Inc reported revenue of $174m, down 15.5% on the year before, operating income of $67.5m (a 38.9% margin) and net income of $51.0m, or $0.50 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue194205174175
Cost of revenue56494649
Gross profit137156127126
Selling, general and administrative66586060
Operating income71706765
Interest expense0000
Income before tax74738275
Income tax35273125
Net income39475149
Diluted EPS$0.42$0.48$0.50$0.48
Diluted shares (average)94m97m103m103m
EBITDA83747068

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: PETS vs SBCAIRS vs SBCNRC vs SBCDLHC vs SBC

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from SBC Medical Group Holdings Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to SBC Medical Group Holdings Inc.